Debate On FDA User Fee Reauthorization Begins To Take Shape

A battle may be forming over the 2027 FDA user fee reauthorizations. At a conference Friday, Democratic Rep. Jake Auchincloss supports them for their effectiveness, while Deputy FDA Commissioner Grace Graham echoed criticisms from HHS Sec. Kennedy, among others, in calling for reform to ensure public trust.

Rep. Jake Auchincloss, D-MA, pictured in front of the Capitol building in 2024.
Rep. Jake Auchincloss, D-MA, pictured in front of the Capitol building in 2024. Auchincloss recently spoke in support of user fee programs. (Philip Yabut/Shutterstock)

More from Legislation

More from Policy & Regulation